Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $4.85 billion as of April 27, 2026. Its market cap has increased by 142.30% in one year.

• Market Cap: 4.85B
• Enterprise Value: 4.56B
• 1-Year Change: 142.30%
• Ranking: #1435
• Category: Mid-Cap
• Stock Price: $241.79

Market Cap Chart

Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $4.85B, an increase of 1,024.67%. That is a compound annual growth rate of 9.23%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	4.61B	23.93%
Dec 31, 2025	3.72B	83.80%
Dec 31, 2024	2.02B	62.58%
Dec 29, 2023	1.25B	10.35%
Dec 30, 2022	1.13B	-56.28%
Dec 31, 2021	2.58B	61.30%
Dec 31, 2020	1.60B	-12.63%
Dec 31, 2019	1.83B	-36.49%
Dec 31, 2018	2.88B	-0.20%
Dec 29, 2017	2.89B	36.08%
Dec 30, 2016	2.12B	-1.70%
Dec 31, 2015	2.16B	102.78%
Dec 31, 2014	1.07B	-0.76%
Dec 31, 2013	1.07B	159.26%
Dec 31, 2012	414.10M	77.34%
Dec 30, 2011	233.50M	33.50%
Dec 31, 2010	174.90M	-28.67%
Dec 31, 2009	245.20M	-5.73%
Dec 31, 2008	260.10M	-43.57%
Dec 31, 2007	460.90M	-46.88%
Dec 29, 2006	867.60M	4.96%
Dec 30, 2005	826.60M	-3.95%
Dec 31, 2004	860.60M	-19.85%
Dec 31, 2003	1.07B	179.68%
Dec 31, 2002	383.90M	-64.11%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Mirum Pharmaceuticals	5.52B
TG Therapeutics	5.41B
Scholar Rock Holding	5.34B
Xenon Pharmaceuticals	5.27B
Apellis Pharmaceuticals	5.24B
Corcept Therapeutics	4.94B
Dianthus Therapeutics	4.76B
CRISPR Therapeutics AG	4.70B